Frightening sight: Dozens of spooky glowing eyes appear from the shadows
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Tag along with Jay at CISCE: 3, 2, 1, Go! Linking you to a better lifestyle
BEIJING, July 22, 2025 /PRNewswire/ -- This is a report from British visitor Jay Ian Birbeck explored the healthy life section of the third China International Supply Chain Expo (CISCE), an event showcasing the full breadth of the global supply chain in Beijing from July 16 to 20. Jay's journey began with a fairytale-inspired AI mirror. When he jokingly asked, "Who's the most handsome guy at CISCE?", a staff member from Dong-E-E-Jiao Co., Ltd explained the real value behind the AI mirror. By scanning the tongue coating and facial complexion in just 10 seconds, the system uses artificial intelligence to enhance TCM's four diagnostic methods and provide real-time personalized health reports and wellness plans. The blend of ancient wisdom and modern technology allowed Jay to witness the vitality of millennia-old traditions in the digital age. At Bloomage Biotech's booth, Jay discovered a skincare innovation made entirely from fermented rice liquid, with no added water — a formulation that caught his attention. Staff further showcased the core engine behind such innovations: the synthetic biology pilot transformation platform. This critical bridge connecting labs to mass production is accelerating the transformation of research ideas into tangible products, offering Jay a glimpse into how China's biomanufacturing is reshaping the future of the beauty industry. At L'Oréal's booth, Jay witnessed the dynamic growth of China's beauty sector firsthand. With a brand portfolio serving 100 million Chinese consumers, the exhibit demonstrated how a robust supply chain underpins innovation in R&D, production, and logistics. What impressed Jay more was a locally developed innovation: a hair dryer co-created with a Chinese startup. Enhanced by infrared light, it delivers unprecedented speed-drying and shine effects. Entering the wellness zone, Jay was drawn to Dong-e-e-jiao's booth by the enticing aroma of traditional remedies. There, he encountered classic tonics creatively reimagined as snack-friendly formats for younger consumers. At T.C. Pharmaceutical Group's section, a Red Bull drink co-branded with CISCE's mascot Linky was precisely delivered by a robot to Jay during a fitness test. Marking the 50th anniversary of China–Thailand diplomatic ties, the Thai enterprise leveraged its investment in China over five years to showcase a new Asian narrative of cross-border supply chain collaboration. Smart home innovations demonstrated the future of comfortable living. Jay experienced heat-insulating and soundproof smart windows, facial-recognition door locks, and hidden range hoods that display recipes while cooking. Moving to Cheers' exhibit, technology embraced humanistic care: a power-lift sofa uses mechanical structures to assist the elderly in standing effortlessly. Staff noted this comfort has reached users in over 100 countries through 15 global production bases. From beauty tech to wellness solutions, the third CISCE brought together a full spectrum of lifestyle advancements. Join Jay as he explores how cutting-edge AI, smart home solutions and pharmaceutical breakthroughs are reshaping health, beauty and modern living. Three, two, one — hit the link and discover a smarter way to live well! Tag along with Jay at CISCE: 3, 2, 1, Go! Linking you to a better lifestylehttp:// View original content to download multimedia: SOURCE Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Japan Genome Editing Market Size, Share & Trends Analysis Report 2025-2033: Japan's Genome Editing Market Set to Reach USD 1.45 Billion by 2033
Japan's genome editing market, valued at USD 1.45 billion by 2033, grows at a 17.97% CAGR, driven by precision medicine and biotech investment. Key technologies like CRISPR/Cas9 lead, supported by regulatory policies and research infrastructure. The market is pivotal for gene therapies, agricultural biotech, and more. Japanese Genome Editing Market Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Japan Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9), By Delivery Method (Ex Vivo), By Application (Genetic Engineering, Clinical Applications), By Mode (Contract, In-house), By End Use, And Segment Forecasts, 2025 - 2033" report has been added to Japanese genome editing market size is projected to reach USD 1.45 billion by 2033, growing at a CAGR of 17.97% from 2025 to 2033. Japan's genome editing market is witnessing robust expansion, propelled by increasing investment in precision medicine, regenerative therapies, and agricultural biotechnology. The growing focus on next-generation therapeutics, particularly gene therapies, rare disease treatments, and personalized oncology solutions, fuels demand for advanced genome editing technologies such as CRISPR-Cas9, TALENs, and base editors. Regulatory encouragement and supportive government initiatives, including funding for biotech innovation and streamlining of clinical approval processes, further accelerate market momentum. A strong academic and research infrastructure and the presence of globally recognized institutions underpin innovation and collaboration across sectors. Pharmaceutical companies, biotech startups, and educational consortia are increasingly converging to translate gene editing breakthroughs into viable clinical and commercial applications. Japan's aging population and rising incidence of chronic genetic disorders are also driving urgency around genome-targeted interventions, catalyzing demand for safe, effective, and scalable editing advancements in delivery systems, precision targeting, and off-target risk mitigation are expanding genome editing's therapeutic applicability. Integration with digital tools and AI-driven bioinformatics platforms is improving target discovery, optimizing design workflows, and accelerating preclinical development. In agriculture and food biotechnology, gene editing is applied to develop disease-resistant, high-yield crops, aligning with national food security and sustainability cross-sector partnerships, increased R&D activity, and supportive policy frameworks, the Japan genome editing market is well-positioned to play a leading role in shaping the future of precision biotechnology. Strategic alliances, localized manufacturing, and a growing IP portfolio reinforce Japan's position as a key hub for genome editing innovation in therapeutic and non-therapeutic Genome Editing Market Report Highlights By technology, CRISPR/Cas9 dominated the Japan genome editing market with a market share of 44.14% in 2024. This dominance stems from CRISPR/Cas9's superior efficiency, precision, and cost-effectiveness in targeted genome modifications. Its widespread adoption across research institutes, biotech startups, and pharmaceutical companies reflects its ability to accelerate functional genomics studies, therapeutic development, and agricultural innovation. The relatively easier design and scalability of CRISPR/Cas9 tools make them the preferred choice for both in vitro and in vivo applications. By delivery method, in vivo genome editing led the market with a market share of 50.63% in 2024, driven by rising investments in gene therapy and regenerative medicine, especially for treating inherited diseases and cancers. Japan's advanced healthcare infrastructure and focus on curative therapies have fueled the development of novel delivery platforms, such as lipid nanoparticles and adeno-associated viral vectors (AAVs), enabling more effective gene transfer in living organisms. The ability to directly edit genes within the patient offers transformative potential and continues to attract clinical trial activity and investment. By application, genetic engineering emerged as the leading segment, with a market share of 73.16% in 2024, contributing the highest revenue share. The segment's growth is driven by Japan's commitment to disease modeling, therapeutic discovery, and functional genomics research. Genetic engineering is widely used across academia and industry to develop customized cell lines, engineer model organisms, and advance gene therapy pipelines. It also plays a crucial role in precision breeding for agriculture and aquaculture, which are strategic sectors in Japan's biotech innovation agenda. By mode, the contract segment held the largest share of 66.77% in 2024, as outsourcing genome editing services becomes increasingly common among biotech startups and research institutions. Contract service providers offer specialized expertise, infrastructure, and regulatory support, allowing innovators to reduce time-to-market and control development costs. Japan's strong contract research and manufacturing organization ecosystem supports gene editing across preclinical, clinical, and commercial phases. By end use, biotechnology and pharmaceutical companies dominated the Japan genome editing market with a share of 49.66% in 2024. These companies leverage genome editing to accelerate drug discovery, develop gene and cell therapies, and explore novel treatment modalities for complex diseases. With robust R&D pipelines and increasing government incentives, these end users are at the forefront of innovation. Collaborations with academic institutions and global biotech firms further strengthen their position, making them central players in the commercial Application of genome editing technologies. In January 2025, Takara Bio USA Holdings, Inc. completed the acquisition of California-based Curio Bioscience, integrating its Trekker and Seeker spatial-biology platforms into its U.S. single-cell omics portfolio. Key Attributes: Report Attribute Details No. of Pages 110 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $323.1 Million Forecasted Market Value (USD) by 2033 $1450 Million Compound Annual Growth Rate 17.9% Regions Covered Japan Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary 2.1. Market Outlook2.2. Segment Snapshot2.3. Competitive Landscape SnapshotChapter 3. Market Variables, Trends, & Scope 3.1. Market Lineage Outlook3.2. Market Dynamics3.3. Japan Genome Editing Market Analysis ToolsChapter 4. Japan Genome Editing Market: Technology Business Analysis 4.1. Technology Segment Dashboard4.2. Japan Genome Editing Market Technology Movement Analysis4.3. Japan Genome Editing Market Size & Trend Analysis, by Technology4.4. CRISPR/Cas94.5. TALENs/MegaTALs4.6. ZFN4.7. Meganucleases4.8. OthersChapter 5. Japan Genome Editing Market: Delivery Method Business Analysis 5.1. Delivery Method Segment Dashboard5.2. Japan Genome Editing Market Delivery Method Movement Analysis5.3. Japan Genome Editing Market Size & Trend Analysis, by Delivery Method5.4. Ex-vivo5.5. In- vivoChapter 6. Japan Genome Editing Market: Application Business Analysis 6.1. Application Segment Dashboard6.2. Japan Genome Editing Market Application Movement Analysis6.3. Japan Genome Editing Market Size & Trend Analysis, by Application6.4. Genetic Engineering6.4.1. Genetic Engineering market estimates and forecasts 2021 to 20336.4.2. Cell line engineering6.4.3. Animal genetic engineering6.4.4. Plant genetic engineering6.4.5. Others6.5. Clinical Applications6.5.1. Clinical Applications market estimates and forecasts 2021 to 20336.5.2. Therapy Development6.5.3. Diagnostics DevelopmentChapter 7. Japan Genome Editing Market: Mode Business Analysis 7.1. Mode Segment Dashboard7.2. Japan Genome Editing Market Mode Movement Analysis7.3. Japan Genome Editing Market Size & Trend Analysis, by Mode7.4. Contract7.5. In- houseChapter 8. Japan Genome Editing Market: End Use Estimates & Trend Analysis 8.1. End Use Segment Dashboard8.2. Japan Genome Editing Market End Use Movement Analysis8.3. Japan Genome Editing Market Size & Trend Analysis, by End Use8.4. Biotechnology & Pharmaceutical Companies8.5. Academic & Research Institutes8.6. Contract Research OrganizationsChapter 9. Competitive Landscape 9.1. Company/Competition Categorization9.2. Strategy Mapping9.3. Company Market Position Analysis, 20249.4. Company Profiles Merck KGaA Takara Bio Inc. Revvity, Inc. Danaher Corporation GenScript New England Biolabs Lonza Thermo Fisher Scientific, Inc. Charles River Laboratories Eurofins Scientific For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Japanese Genome Editing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
a day ago
- Associated Press
Chun Wo Innovation Student Awards 2024 Successfully Concluded Four Outstanding Projects Showcase the Future of Engineering Innovation
HONG KONG SAR - Media OutReach Newswire - 29 July 2025 - Organised by Chun Wo Development Holdings Limited ('Chun Wo'), the Chun Wo Innovation Student Awards 2024 ('CWISA') concluded successfully with an award presentation ceremony celebrating a new generation of engineering talent and their innovative solutions. Themed 'Engineers: Overcoming World's Challenges', this year's competition attracted over 40 teams from 18 higher education institutions and universities across Hong Kong and the Greater Bay Area. By using cutting-edge technologies such as Artificial Intelligence (AI), Robotics, and Augmented/Virtual Reality (AR/VR) to develop engineering solutions for 'Climate Action', 'Sustainable Cities and Communities', and 'Innovative Architecture and Infrastructure'. The award ceremony was attended by government officials, industry leaders, and academic representatives. A total of HKD 200,000 in cash prize was presented across the Gold, Silver, Bronze, and Merit Awards. Chun Wo will assist winning teams to execute their innovative ideas by providing appropriate resources or investments. Sr Stephen LEE, Chairman of Chun Wo Construction Holdings Company Limited remarks, 'It is inspiring to witness the rise of future talents in engineering and innovation from Hong Kong and the Greater Bay Area. By leveraging innovation and technology to address challenges like infrastructure and climate change, the students have shown immense potential. We hope the award-winning students will continue to explore new possibilities and work together to create a better future for society.' Ir Michael FONG, JP, Director of the Civil Engineering and Development remarks, 'Having served as a judge for two consecutive years, I am deeply impressed by the level of innovation showcased in this year's entries — it not only demonstrates the students' growing ambition in their creations but also reflects the younger generation's spirit of breaking conventions and pioneering new possibilities.' The Gold Award of CWISA 2024 was presented to a team from The Hong Kong Polytechnic University for their project 'Renewable Material Coagulant', which uses industrial by-products to develop a low-carbon solidifying agent as a replacement for traditional cement in ground stabilisation. The project achieves more than 80% carbon emission reduction and offers a revolutionary alternative for green construction and land rehabilitation. The Silver Award went to a cross-institutional team from The Chinese University of Hong Kong, The University of Hong Kong, The Hong Kong University of Science and Technology, and The Hong Kong Polytechnic University. Their project 'RiceFort' upcycles discarded rice husks into eco-friendly fibreboards for use in furniture and construction. The project demonstrates high performance, low cost, and recyclability, and also won the Best Social Impact Award for its green entrepreneurship potential and community value. The Bronze Award was awarded to a team from City University of Hong Kong for their project 'AI-Driven Self-cleaning Air-to-Hydrogen System', which combines air-to-water extraction, solar photocatalysis, and AI-powered self-cleaning to produce hydrogen with zero carbon emissions and no external water consumption. The solution is especially suitable for arid and remote areas, and also won the Best Sustainable Solution Award. In addition, a joint team from The University of Hong Kong, City University of Hong Kong, and The Hong Kong Polytechnic University won the Best Business Potential Award for their project 'Generation Alpha Building Emergency System', which features an AIoT-powered fire detection system with high accuracy and low false alarm rates, offering an advanced fire safety solution for older buildings and high-density urban environments. Chun Wo aims to continuously inspire the creativity and sense of social responsibility among young engineers through the CWISA platform. The company will continue working with academia, industry, and government partners to promote the implementation of innovative technologies and nurture more engineering talent with global vision and a commitment to sustainability, contributing to a smarter and greener future. Download High-Resolution Photos HERE Photo Captions: Hashtag: #ChunWoDevelopment The issuer is solely responsible for the content of this announcement. About Chun Wo Innovation Student Awards The Chun Wo Innovation Student Awards ('CWISA') is a biennial competition established in 2018 by Chun Wo Development Holdings Limited. It aims to inspire young innovators to develop creative engineering solutions that strengthen urban connectivity and promote sustainable city development. Since its inception, CWISA has attracted over 650 students from more than 20 tertiary institutions and universities across Hong Kong and the Greater Bay Area. The fourth CWISA is themed 'Engineers Overcoming the World's Challenges,' motivates students to propose innovative engineering solutions in response to climate action, sustainable cities and communities, and innovative architecture and infrastructure. By leveraging emerging technologies such as artificial intelligence (AI), robotics, and augmented/virtual reality (AR/VR), students are encouraged to help shape a better future for society and the environment. The Awards recognise outstanding ideas with Gold, Silver, Bronze, and Merit Awards. The Gold Award winner will receive a cash prize of HK$100,000, with a total cash prize of approximately HK$200,000 for all winners. For more information, please visit: About Chun Wo Development Holdings Limited Chun Wo Development Holdings Limited ('Chun Wo') was founded in 1968 and is a key subsidiary of Asia Allied Infrastructure Holdings Limited (stock code: The Company is principally engaged in the core construction and property development businesses with the professional capability to undertake large integrated construction projects. Recent examples of large infrastructure projects which the Company has undertaken works include the Tseung Kwan O – Lam Tin Tunnel Tseung Kwan O Interchange, the Central-Wan Chai Bypass, the Liantang/Heung Yuen Wai Boundary Infrastructure, the Hong Kong-Zhuhai-Macao Bridge Passenger Clearance Building, the Guangzhou-Shenzhen-Hong Kong Express Rail Link (Hong Kong Section), the MTR Shatin to Central Link and the Redevelopment of Kwong Wah Hospital (Phase 2) etc. About Asia Allied Infrastructure Holdings Limited (Stock Code: Asia Allied Infrastructure Holdings Limited ('Asia Allied Infrastructure', 'the Group') is listed on the Main Board of the Hong Kong Stock Exchange under stock code 00711. The Group operates businesses such as construction engineering and management, property development and assets leasing, security and facility management, tunnel management, non-franchised bus services, as well as medical technology and healthcare. Its subsidiary 'Chun Wo' is a renowned construction contractor and property developer in Hong Kong. Chun Wo's solid construction experience and professional capabilities have enabled the Group to seize suitable development opportunities, allowing the Group to enhance its overall profitability and investment value.
